FindTrial
Sign In

RESEARCH FOR EFFECTIVENESS AND SAFETY OF A DRUG MIFEPRISTONE 100 MG FOR ONCE IN A MONTH CONTRACEPTIVE PILL.

STUDY OF THE EFFICACY AND SAFETY OF ONCE IN A MONTH 100 MG SINGLE DOSE OF MIFEPRISTONE (RU-486)AS A CONTRACEPTIVE AGENT. - MOM 100

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006608
Enrollment
200
Registered
2016-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: MIFEPRISTONE: 100MG ONCE MONTHLY ORAL SUPERVISED FOR 12 MONTHS Control Intervention1: combined oral contraceptive pill (mala-n): mala-n contains estrogen (ethinyl estradiol 0.03mg) and

Sponsors

INDIAN COUNCIL OF MEDICAL RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy female volunteers who are willing to get contraceptive advice haning at least one living child and regular menstrual cycle

Exclusion criteria

Exclusion criteria: pregnant and lactating mothers nulliparous women any hematological disease bleeding diasthesis any dysplasia or malignancy any cardiovascular disorder diabetes mellitus type 1 and 2 thyroid dysfunction hypertension genito urinary tract abnormalities any liver or kidney disorder known allergic to mifepristone and contraceptive pill any abnormal vaginal discharge or bleeding pv any history of ectopic pregnancy known pelvic inflammatory disease women on steroid therapy or steroid dependence women already practicing any contraceptive method other than barrier methods women unwilling to undergo abortion if pregnancy occurs due to drug failure

Design outcomes

Primary

MeasureTime frame
CONTRACEPTIONTimepoint: AFTER 2 YEARS—

Secondary

MeasureTime frame
compliance side effects and satisfactionTimepoint: monthly—

Countries

India

Contacts

Public ContactDR AMIT KUMAR GHOSH

R.G.KAR MEDICAL COLLEGE

dyregistraramitghosh@gmail.com9432305660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026